Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study

N. Madetko-Alster, P. Alster, T. Bartošová, J. Klempíř, B. Migda, D. Przewodowska, A. Migda, A. Friedman

. 2023 ; 57 (2) : 177-182. [pub] 20221215

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010733

INTRODUCTION: Corticobasal syndrome (CBS) is a specific clinical manifestation shared by multiple pathologies. The exact mechanism of this phenomenon remains unclear. Differential diagnosis of CBS in everyday clinical practice is challenging, as this syndrome can overlap with other entities, especially progressive supranuclear palsy Richardson-Steele phenotype (PSP-RS). Several papers have suggested a possible role of vascular pathology as a linking factor in the pathogenesis of CBS based on different neuropathologies. This paper analyses differences in the occurrence of the most common vascular risk factors such as hypertension and lipid profile with respect to dietary habits among patients who fulfill the diagnostic criteria for probable/possible CBS and PSP-RS. MATERIAL AND METHODS: Seventy (70) patients in total were included in the study. Exclusion criteria comprised hydrocephalus, stroke in the past, the presence of marked vascular changes in white matter defined as the presence of vascular change ≥ 1 mm in 3T MRI, medical history of hyperlipidemia or the use of drugs that could impact upon lipid metabolism before the initiation of the neurodegenerative disease, and neoplastic focuses in the central nervous system. Patients with diabetes, or with BMI exceeding 18-25, or who were smokers, or who were affected by chronic stress were also excluded. Data was analysed statistically using the Shapiro-Wilk test, the U Mann-Whitney test for group comparison, and a Bonferroni correction to control the false discovery rate (FDR). RESULTS: Our obtained results indicated a statistically significantly higher level of total cholesterol in the CBS group (p = 0.0039) without a correlation with dietary habits. CONCLUSIONS AND CLINICAL IMPLICATIONS: The results obtained in our study may suggest a possible role of vascular pathology in CBS development. This issue requires further research.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010733
003      
CZ-PrNML
005      
20250225083047.0
007      
ta
008      
230718s2023 pl f 000 0|eng||
009      
AR
024    7_
$a 10.5603/PJNNS.a2022.0078 $2 doi
035    __
$a (PubMed)36519660
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Madetko-Alster, Natalia $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland. natalia.madetko@wum.edu.pl $1 https://orcid.org/000000018685475X
245    10
$a Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study / $c N. Madetko-Alster, P. Alster, T. Bartošová, J. Klempíř, B. Migda, D. Przewodowska, A. Migda, A. Friedman
520    9_
$a INTRODUCTION: Corticobasal syndrome (CBS) is a specific clinical manifestation shared by multiple pathologies. The exact mechanism of this phenomenon remains unclear. Differential diagnosis of CBS in everyday clinical practice is challenging, as this syndrome can overlap with other entities, especially progressive supranuclear palsy Richardson-Steele phenotype (PSP-RS). Several papers have suggested a possible role of vascular pathology as a linking factor in the pathogenesis of CBS based on different neuropathologies. This paper analyses differences in the occurrence of the most common vascular risk factors such as hypertension and lipid profile with respect to dietary habits among patients who fulfill the diagnostic criteria for probable/possible CBS and PSP-RS. MATERIAL AND METHODS: Seventy (70) patients in total were included in the study. Exclusion criteria comprised hydrocephalus, stroke in the past, the presence of marked vascular changes in white matter defined as the presence of vascular change ≥ 1 mm in 3T MRI, medical history of hyperlipidemia or the use of drugs that could impact upon lipid metabolism before the initiation of the neurodegenerative disease, and neoplastic focuses in the central nervous system. Patients with diabetes, or with BMI exceeding 18-25, or who were smokers, or who were affected by chronic stress were also excluded. Data was analysed statistically using the Shapiro-Wilk test, the U Mann-Whitney test for group comparison, and a Bonferroni correction to control the false discovery rate (FDR). RESULTS: Our obtained results indicated a statistically significantly higher level of total cholesterol in the CBS group (p = 0.0039) without a correlation with dietary habits. CONCLUSIONS AND CLINICAL IMPLICATIONS: The results obtained in our study may suggest a possible role of vascular pathology in CBS development. This issue requires further research.
650    _2
$a lidé $7 D006801
650    _2
$a pilotní projekty $7 D010865
650    12
$a kortikobazální degenerace $7 D000088282
650    12
$a neurodegenerativní nemoci $x etiologie $x diagnóza $x patologie $7 D019636
650    12
$a hyperlipidemie $7 D006949
650    12
$a progresivní supranukleární obrna $x diagnóza $x patologie $7 D013494
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Alster, Piotr $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
700    1_
$a Bartošová, Tereza $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic $7 xx0240060
700    1_
$a Klempíř, Jiří $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University, General University Hospital in Prague, Czech Republic
700    1_
$a Migda, Bartosz $u Diagnostic Ultrasound Lab, Department of Pediatric Radiology, Medical Faculty, Medical University of Warsaw, Poland
700    1_
$a Przewodowska, Dominika $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
700    1_
$a Migda, Anna $u Department of Internal Medicine and Endocrinology, Medical University of Warsaw,, Warsaw, Poland
700    1_
$a Friedman, Andrzej $u Department of Neurology, Medical University of Warsaw, Kondratowicza 8, 03/242 Warsaw, Poland
773    0_
$w MED00003489 $t Neurologia i neurochirurgia polska $x 0028-3843 $g Roč. 57, č. 2 (2023), s. 177-182
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36519660 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20250225083044 $b ABA008
999    __
$a ok $b bmc $g 1963278 $s 1196998
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 57 $c 2 $d 177-182 $e 20221215 $i 0028-3843 $m Neurologia i Neurochirurgia Polska $n Neurol Neurochir Pol $x MED00003489
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...